IGF2 and cancer: According to the present scenario, and requiring further investigation, the IGF-II/IRA autocrine loop could provide a post-translational pathway aimed at gaining and maintaining high ectopic levels of the EphB4 protein in a number of cancer cells co-expressing such autocrine loop circuitry and degradation factor components [26,55].